Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2021 - 10 - 07 tags : Therapy save search
BioCardia Announces First Cross-Over Patient Treated in CardiAMP Cell Therapy Heart Failure Trial
Published: 2021-10-07 (Crawled : 23:00) - biospace.com/
BCDA P | $0.376 -2.56% 64K
|
Health Technology
|
| O: 2.15%
H: 8.07%
C: 4.21%
heart therapy trial cardiamp
Pan-Cancer Analysis Suggests Fibroblast Activation Protein (FAP) is an Attractive Target for Peptide-Targeted Radionuclide Therapy with FAP-2286
Published: 2021-10-07 (Crawled : 22:00) - biospace.com/
CLVS | $0.0812 -3.94%
|
Health Technology
|
| O: 2.08%
H: 2.04%
C: -0.23%
therapy cancer
Jounce Therapeutics Progresses INNATE Study of JTX-8064 (LILRB2/ILT4 Inhibitor) Monotherapy and Pimivalimab (PD-1 Inhibitor) Combination Therapy in Patients with Advanced Solid Tumors
Published: 2021-10-07 (Crawled : 12:15) - globenewswire.com
JNCE | $1.88 -2.59% -1.85% 0
|
Health Technology
|
| O: 1.32%
H: 2.21%
C: 1.3%
GILD | $67.07 0.06% 0.06% 8.3M
|
Health Technology
|
| O: 0.03%
H: 1.21%
C: 0.95%
solid tumors therapy pimivalimab pd-1 inhibitor
Editas Medicine to Present Preclinical Data on Novel Engineered iPSC Derived NK Cells for the Treatment of Cancer at the Society for Immunotherapy of Cancer 36th Annual Meeting
Published: 2021-10-07 (Crawled : 12:15) - globenewswire.com
EDIT | News | $5.355 -1.92% -1.96% 1.6M
|
Health Technology
|
| O: 0.99%
H: 5.99%
C: 2.95%
treatment immunotherapy therapy cancer preclinical pre-clinical
Rapid Growth in Drug Discovery and New Therapy Research Spurring Sales of Chromatographic Separation Resins to reach 2x by 2031
Published: 2021-10-07 (Crawled : 12:00) - prnewswire.com
BIO | $278.21 -2.48% 0.0% 210K
|
Health Technology
|
| O: 0.61%
H: 1.87%
C: 0.58%
sales therapy drug discovery drug growth research
Amgen and Neumora Therapeutics Announce Strategic R&D Collaboration to Accelerate Novel Precision Therapies for Brain Diseases
Published: 2021-10-07 (Crawled : 12:00) - biospace.com/
BGNE | $144.0 3.61% 3.48% 220K
|
Health Technology
|
| O: 1.77%
H: 4.53%
C: 4.35%
AMGN | News | $273.085 -0.17% -0.17% 2.5M
|
Health Technology
|
| O: -0.69%
H: 1.88%
C: 0.28%
disease collaboration therapy train
ATP Unveils Non-Viral Gene Therapy Innovator Intergalactic Therapeutics with $75 Million in Series A Funding
Published: 2021-10-07 (Crawled : 12:00) - biospace.com/
SNYNF | News | $94.25 -2.18% 480
|
Health Technology
|
| O: -4.14%
H: 5.79%
C: 5.79%
CTS | News | $45.64 0.33% 0.0% 94K
|
Electronic Technology
|
| O: 0.99%
H: 1.71%
C: 0.7%
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
|
| O: 0.21%
H: 0.95%
C: 0.62%
funding gene therapy therapy
Gainers vs Losers
| 62% | 38% |
Top 10 Gainers
CSSE 4 | $0.4323 183.85% 64.77% 220M
|
Consumer Services
BOF | $1.99 70.09% 41.21% 110M
|
ILAG | $0.51 6.03% 40.62% 1.7M
|
LICN | $0.941 68.04% 40.49% 15M
|
AMST | $3.31 65.5% 39.58% 70M
|
Technology Services
MTC | $3.615 61.38% 38.04% 9.3M
|
Technology Services
WIMI | $1.15 58.53% 36.92% 19M
|
Technology Services
AIH | $0.45 12.5% 30.92% 320K
|
Health Services
MULN | News | $3.78 38.46% 27.78% 13M
|
Information
RILY | $29.86 37.48% 27.26% 12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.